Management of acquired haemophilia A - More questions than answers

Blood Coagulation and Fibrinolysis

Volumn 14, Issue SUPPL. 1, 2003, Pages

  Collins, Peter W ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Autoantibody; Factor Eight Inhibitor bypassing activity; Haemophilia; Inhibitors; Recombinant factor VIIa

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ARGIPRESSIN[1 DEAMINO]; AZATHIOPRINE; BLOOD CLOTTING FACTOR 8 ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; VINCRISTINE;

AUTOIMMUNITY; CLINICAL FEATURE; CONFERENCE PAPER; DRUG SAFETY; HEMOPHILIA A; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; PARTIAL THROMBOPLASTIN TIME; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REMISSION;

ADRENAL CORTEX HORMONES; ADULT; ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIAS (EPIDEMIOLOGY); BLOOD COAGULATION FACTORS; DEAMINO ARGININE VASOPRESSIN; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; POSTPARTUM HEMORRHAGE; PREGNANCY; RETROSPECTIVE STUDIES; SWINE;

EID: 0042125122     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200306001-00006     Document Type: Conference Paper

References (20)

1. Hay CRM. Acquired haemophilia. In Bailliere's Clinical Haematology. London: Ballieres; 1998; 11:287-303.
2. Kessler CM, Nemes L. Acquired inhibitors to factor VIII. In: Rodriguez-Merchan EC, Lee CA (editors): Inhibitors in patients with haemophilia. Oxford: Blackwell Science; 2002. pp. 98-112.
3. Hay CRM, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78:1463-1467.
4. Lottenberg R, Kentro TB, Kitchens CS. Acquired haemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med 1987; 147:1077-1081.
5. Green D and Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45:200-203.
6. Hauser I, Schneider B, Lechner K. Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995; 73:1-5.
7. Solymoss S. Postpartum acquired factor VIII inhibitors: results of a survey. Am J Hematol 1998; 59:1-4.
8. Algiman M, Dietrich G, Nydegger UE, Boieldieu D, Sultan Y, Kazatchkine MD. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci USA 1992; 89:3795-3799.
9. Green D, Rademaker AW, Briët E. A prospective, randomised trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993; 70:753-757.
10. Lian EC, Larcada AF, Chiu AY. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989; 110:774-778.
11. Nemes L, Pitlik E. New protocol for immune tolerance induction in acquired haemophilia. Haematologica 2000; 85(Suppl):64-68.
12. Sultan Y, Kazatchkine MD, Nydegger U, Rossi F, Dietrich G, Algiman M. Intravenous immunoglobulin in the treatment of spontaneously acquired factor VIII:C inhibitors. Am J Med 1991; 91:S35-S39.
13. Schwarz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995; 86:797-804.
14. Dykes AC, Walker ID, Lowe GD, Tait RC. Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia 2001; 7:160-163.
15. Wiestner A, Cho HJ, Asch AS, Michelis MA, Zeller JA, Peerschke EI, et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002; 100:3426-3428.
16. Morrison AE, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired haemophilia. Blood 1993; 81:1513-1520.
17. Grunewald M, Beneke H, Guthner C, Germowitz A, Brommer A, Griesshammer M. Acquired haemophilia: experiences with a standardized approach. Haemophilia 2001; 7:164-169.
18. Mudad R, Kane WH. DDAVP in acquired hemophilia A: case report and review of the literature. Am J Hematol 1993; 43:295-299.
19. Jansen M, Schmaldienst S, Banyai S, Quehenberger P, Pabinger I, Derfler K, et al. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb). Br J Haematol 2001; 112:91-97.
20. Guillet B, Kriaa F, Huysse MG, Proulle V, George C, Tchernia G, et al. Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia. Br J Haematol 2001; 114:837-844.